Neuron creation in the region of the brain linked to learning and memory decreases sharply during childhood and is almost undetectable in adults, new research shows.
The FDA has announced a plan to modernise its approach to evaluating new drugs for Alzheimer’s and other neurologic diseases.
New research suggests that the first modern Briton from 300 generations ago, had a darker complexion than first thought, as well as blue eyes and curly hair.
A simple technique to gauge brain levels of a toxic protein could improve diagnosis and drug trials, to help in the quest to diagnose and treat Alzheimer’s disease.
A drug developed for type 2 diabetes has “significantly reversed memory loss” in mice with Alzheimer’s disease, and researchers now want to test it on humans.
Scientists have identified differences in a group of genes they say might help explain why some people need a lot more sleep, and others less, than most.
An adapted CRISPR technique could be used to treat incurable diseases, such as diabetes and muscular dystrophy, by turning up the volume on selected genes.
Using ‘Raman’ optical technology, scientists can now produce images of brain tissue that is affected by Alzheimer’s disease.
A type of abnormal protein thought to be the cause of Creutzfeldt-Jakob has been found in the skin of 23 patients who died from the disease
One under the radar biotech could be trumping all its competitors, after it makes significant progress in potentially producing an Alzheimer’s treatment.